IL155926A0 - An extended tethering approach for rapid identification of ligands - Google Patents

An extended tethering approach for rapid identification of ligands

Info

Publication number
IL155926A0
IL155926A0 IL15592601A IL15592601A IL155926A0 IL 155926 A0 IL155926 A0 IL 155926A0 IL 15592601 A IL15592601 A IL 15592601A IL 15592601 A IL15592601 A IL 15592601A IL 155926 A0 IL155926 A0 IL 155926A0
Authority
IL
Israel
Prior art keywords
rapid identification
ligands
tethering approach
extended tethering
binding partners
Prior art date
Application number
IL15592601A
Other languages
English (en)
Original Assignee
Sunesis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunesis Pharmaceuticals Inc filed Critical Sunesis Pharmaceuticals Inc
Publication of IL155926A0 publication Critical patent/IL155926A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Structural Engineering (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Control And Safety Of Cranes (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
IL15592601A 2000-11-21 2001-11-20 An extended tethering approach for rapid identification of ligands IL155926A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25229400P 2000-11-21 2000-11-21
PCT/US2001/044036 WO2002042773A2 (en) 2000-11-21 2001-11-20 An extended tethering approach for rapid identification of ligands

Publications (1)

Publication Number Publication Date
IL155926A0 true IL155926A0 (en) 2003-12-23

Family

ID=22955415

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15592601A IL155926A0 (en) 2000-11-21 2001-11-20 An extended tethering approach for rapid identification of ligands
IL155926A IL155926A (en) 2000-11-21 2003-05-15 An extended ligation approach for rapid identification of ligands

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155926A IL155926A (en) 2000-11-21 2003-05-15 An extended ligation approach for rapid identification of ligands

Country Status (14)

Country Link
EP (2) EP1337853B1 (ja)
JP (2) JP3836791B2 (ja)
AT (1) ATE420366T1 (ja)
AU (2) AU2573102A (ja)
CA (1) CA2430234C (ja)
DE (1) DE60137356D1 (ja)
DK (1) DK1337853T3 (ja)
ES (1) ES2322796T3 (ja)
HK (1) HK1063844A1 (ja)
IL (2) IL155926A0 (ja)
MX (1) MXPA03004435A (ja)
NZ (1) NZ525861A (ja)
WO (1) WO2002042773A2 (ja)
ZA (1) ZA200303772B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214487B2 (en) 1998-06-26 2007-05-08 Sunesis Pharmaceuticals, Inc. Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
US6998233B2 (en) 1998-06-26 2006-02-14 Sunesis Pharmaceuticals, Inc. Methods for ligand discovery
IL159983A0 (en) * 2001-08-07 2004-06-20 Sunesis Pharmaceuticals Inc Disulfide and thiosulfonate ligands and libraries comprising these ligands
MXPA04004814A (es) * 2001-11-21 2004-08-11 Sunesis Pharmaceuticals Inc Metodos para descubrir ligandos.
WO2003081210A2 (en) 2002-03-21 2003-10-02 Sunesis Pharmaceuticals, Inc. Identification of kinase inhibitors
BRPI0215858B1 (pt) 2002-07-24 2020-11-10 Keddem Bio-Science Ltd método para obter informações a respeito de uma área quimicamente ativa de uma molécula-alvo
AU2003290304A1 (en) 2002-12-23 2004-07-14 Astex Technology Limited Synthesis and screening of ligands using x-ray crystallography
EP1670422A4 (en) * 2003-09-17 2007-08-01 Sunesis Pharmaceuticals Inc IDENTIFICATION OF KINASE INHIBITORS
EP1682525B1 (en) * 2003-11-14 2013-12-25 3M Innovative Properties Company N-sulfonylaminocarbonyl containing compounds
WO2005101019A2 (en) * 2004-04-12 2005-10-27 University Of Vermont And State Agricultural College Detection of nitrosylated proteins
JP2008520207A (ja) * 2004-11-16 2008-06-19 アヴィディア リサーチ インスティテュート タンパク質骨格およびその使用
US20080070802A1 (en) * 2006-08-23 2008-03-20 Moerschell Richard P Directed heterobifunctional linkers
EP2560686A2 (en) 2010-04-21 2013-02-27 Novo Nordisk A/S Selective modification of proteins
US9102614B2 (en) 2010-07-02 2015-08-11 Gilead Sciences, Inc. Naphth-2-ylacetic acid derivatives to treat AIDS
JP5806735B2 (ja) 2010-07-02 2015-11-10 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖ抗ウイルス化合物としての２−キノリニル−酢酸誘導体
AP2015008931A0 (en) 2011-04-21 2015-12-31 Gilead Sciences Inc Benzothiazole compounds and their pharmaceutical use
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
UY34750A (es) 2012-04-20 2013-11-29 Gilead Sciences Inc ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
EP3033625B1 (en) * 2013-08-13 2020-01-22 The Scripps Research Institute Cysteine-reactive ligand discovery in proteomes
WO2015113476A1 (zh) * 2014-01-29 2015-08-06 上海恒瑞医药有限公司 配体-细胞毒性药物偶联物、其制备方法及其应用
RU2708461C2 (ru) * 2015-02-15 2019-12-09 Цзянсу Хэнжуй Медсин Ко., Лтд. Конъюгат лиганда с цитотоксическим лекарственным средством, способ его получения и применение
WO2017070611A1 (en) * 2015-10-22 2017-04-27 The Scripps Research Institute Cysteine reactive probes and uses thereof
GB201614152D0 (en) 2016-08-18 2016-10-05 Imp Innovations Ltd Assay
EP3570829A4 (en) 2017-01-18 2021-03-10 The Scripps Research Institute PHOTOREACTIVE LIGANDS AND USES THEREOF
US20180372751A1 (en) * 2017-06-23 2018-12-27 The Scripps Research Institute Lysine reactive probes and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011436A1 (en) * 1996-09-13 1998-03-19 Whitehead Institute For Biomedical Research Non-specific affinity enhancement to identify combinatorial library members
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6335155B1 (en) * 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules

Also Published As

Publication number Publication date
HK1063844A1 (en) 2005-01-14
EP1337853A2 (en) 2003-08-27
AU2002225731B2 (en) 2005-04-14
MXPA03004435A (es) 2005-01-25
WO2002042773B1 (en) 2002-12-12
EP1441228A1 (en) 2004-07-28
DE60137356D1 (de) 2009-02-26
AU2573102A (en) 2002-06-03
JP3836791B2 (ja) 2006-10-25
EP1441228B1 (en) 2006-06-28
ZA200303772B (en) 2004-05-17
IL155926A (en) 2009-06-15
WO2002042773A2 (en) 2002-05-30
NZ525861A (en) 2004-09-24
DK1337853T3 (da) 2009-05-04
ES2322796T3 (es) 2009-06-29
CA2430234A1 (en) 2002-05-30
CA2430234C (en) 2008-02-12
JP2004514891A (ja) 2004-05-20
EP1337853B1 (en) 2009-01-07
JP2006113077A (ja) 2006-04-27
WO2002042773A3 (en) 2002-11-14
ATE420366T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
HK1063844A1 (en) An extended tethering approach for rapid identification of ligands
IL161016A (en) Polypeptides capable of ang-2 binding
WO2003040288A3 (de) Isotopencodierte affinitätsmarker 3
PL364623A1 (en) Binding domain-immunoglobulin fusion proteins
IS5769A (is) Taugasæknir thættir
HK1120556A1 (en) Neurotrophic factors
IL200404A0 (en) 191P4D12(b) PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME; ANTIBODIES BINDING THERETO AND USES THEREOF
EP1071460A4 (en) INTERNALIZING ERB2 ANTIBODIES
RS51437B (en) AGENTS SPECIFICALLY BINDING ANGIOPOETIN-2
IL169804A (en) 254p1d6b proteins, nucleic acids encoding the same, processes for producing the same, antibodies binding thereto and uses thereof
PL365735A1 (en) Antibodies specific for cd44v6
MXPA03008706A (es) Encendedor multimodal.
PT1118268E (pt) Metodo para a criopreservacao de esperma de peixe-zebra
AP2006003544A0 (en) Amino acids with affinity for the alpha2delta-protein.
EP1377307A4 (en) ANTI-GPE ANTIBODIES, APPLICATIONS THEREOF AND ANALYTICAL METHODS RELATED TO GPE
HK1053451A1 (en) Binding machine with tape.
WO2003040093A3 (de) Isotopencodierte affinitätsmarker 2
WO2002042777A3 (de) Modulierung der wechselwirkung zwischen evh1-domänen
WO2002050120A3 (en) High affinity antibodies
WO2002052274A3 (fr) Procede de criblage base sur les partenaires de liaison de tsap6
WO2000073345A3 (en) Antibodies specific for mycobacterial polypeptides and uses thereof
DE60219446D1 (de) Plasmabrenner zur erwärmung von geschmolzenem stahl
GB0119446D0 (en) Binding proteins
HRP20030931A2 (en) Antibodies specific for cd44v6
ES1050567U (es) Bloque de hormigon forjado de hierro en forma de "l".